Wake County commissioners have cleared Atrium Health and WakeMed to pursue their proposed combination, approving the required corporate changes after the systems revised the deal to include a five-year limit on price increases, more charity care and a fully funded $2 billion capital commitment.
The Board of Commissioners voted 5-2 on Monday to amend WakeMed’s articles of incorporation, the step needed before the hospital systems can formally seek regulatory approval. Commissioners Vickie Adamson and Tara Waters opposed the measure, while the other five members backed it, according to Axios. The vote does not close the transaction: Atrium and WakeMed still must submit it for federal review by the Federal Trade Commission and Department of Justice.
The county action followed a late revision of the financial terms. Gov. Josh Stein said Atrium agreed to cap WakeMed price increases at no more than 1.5 times the annual increase in Medicare costs for five years. Atrium also committed to supply all of the promised $2 billion for Wake County capital projects, raise minimum indigent care from 4.8 percent to 8 percent of adjusted revenue and establish a $150 million community health fund, according to the governor’s statement.
Those provisions address the two central arguments surrounding the deal. WakeMed says it needs outside capital to renovate its aging Raleigh campus and remain competitive as hospital ownership consolidates. Critics have warned that consolidation can raise costs and reduce local control. Wake County will continue appointing eight of WakeMed’s 14 board members, but Atrium would become the nonprofit system’s sole corporate member, giving the Charlotte-based organization decisive structural authority.
Important details remain unfinished. County Attorney Roger Askew told commissioners that the precise language governing the price cap and $2 billion guarantee had not yet been drafted. The board made its approval conditional on adding those commitments to the private contract, NC Health News reported. That means the public promises are now conditions of the county’s consent, but their enforceability will depend on the final transaction documents and subsequent regulatory review.
The vote also exposed continuing disagreement over process. Opponents argued that major revisions arrived too close to the meeting for meaningful public scrutiny and that the county had not adequately explored alternatives. Supporters said the revised package supplies the capital WakeMed needs while preserving public benefits and a measure of local governance. Commission Chair Don Mial called the decision consequential for the county’s health-care future.
Stein said after the vote that he appreciated the stronger terms but would continue monitoring the transaction as it advances, according to a separate response. The next practical test is whether the final contracts reflect the commitments announced before the vote and whether federal reviewers conclude the combination will preserve competition in the Triangle’s health-care market.
